PERRONE, GIUSEPPE
PERRONE, GIUSEPPE
A RARE CASE OF SOLITARY FIBROUS TUMOUR OF THE PRE-SACRAL SPACE: MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL FEATURES.
2005 E., Cristi; Perrone, Giuseppe; C., Battista; BENEDETTI PANICI, Pierluigi; C., Rabitti
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer
2006 Santini, D; Altomare, A; Vincenzi, B; Perrone, G; Bianchi, A; Rabitti, C; Montesarchio, V; Esposito, V; Baldi, A; Tonini, G.
ANGIOGENESIS AND ONCOGENES IN COLON CANCER
2004 Perrone, G; Verz, A; Vincenzi, B; Santini, D; Tonini, G; Vetrani, A; Rabitti, C
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival
2013 Morini, S; Perrone, G; Borzomati, D; Vincenzi, B; Rabitti, C; Righi, D; Castri, F; Manazza, Ad; Santini, D; Tonini, G; Coppola, R; Onetti Muda, A
Cell cycle alterations and lung cancer
2006 Vincenzi, B; Schiavon, G; Silletta, M; Santini, D; Perrone, G; Di Marino, M; Angeletti, S; Baldi, A; Tonini, G
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature
2014 Valeri, S; Borzomati, D; Nappo, G; Perrone, G; Santini, D; Coppola, R.
Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer
2004 Perrone, G; Vincenzi, B; Santini, D; Verzì, A; Tonini, G; Vetrani, A; Rabitti, C.
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables
2006 Perrone, G; Santini, D; Verzì, A; Vincenzi, B; Borzomati, D; Vecchio, F; Coppola, R; Antinori, A; Magistrelli, P; Tonini, G; Rabitti, C
COX-2 EXPRESSION IN AMPULLARY CARCINOMAS: CORRELATION WITH HISTOPATHOLOGIC TYPE AND CLINICO-PATHOLOGICAL PARAMETERS
2005 Perrone, G; Verz, A; Santini, D; Vincenzi, B; Borzomati, D; DE DOMINICIS, E; Coppola, R; Tonini, G; Rabitti, C
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features
2005 Perrone, G; Santini, D; Vincenzi, B; Zagami, M; La Cesa, A; Bianchi, A; Altomare, V; Primavera, A; Battista, C; Vetrani, A; Tonini, G; Rabitti, C
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma
2008 Perrone, G; Santini, D; Zagami, Mg; Vincenzi, B; Verzì, A; Morini, S; Borzomati, D; Coppola, R; Antinori, A; Magistrelli, P; Tonini, G; Rabitti, C
COX-2 EXPRESSION IN DUCTAL AND LOBULAR INTRAEPITHELIAL NEOPLASIA OF BREAST CANCER
2005 Zagami, M; Perrone, G; Bianchi, A; Santini, D; Vincenzi, B; Altomare, V; Tonini, G; Rabitti, C
COX-2 EXPRESSION IN INTRADUCTAL BREAST CARCINOMA
2004 Perrone, G; Zagami, M; Santini, D; Vincenzi, B; Bianchi, A; LA CESA, A; Altomare, V; Primavera, A; Battista, C; Vetrani, A; Tonini, G; Rabitti, C
COX-2 EXPRESSION IN LOBULAR CARCINOMA IN SITU
2005 Zagami, M; Perrone, G; Bianchi, A; Santini, D; Vincenzi, B; Altomare, V; Primavera, A; Lescarini, G; Tonini, G; Rabitti, C
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification
2007 Perrone, G; Zagami, M; Santini, D; Vincenti, B; Gullotta, G; Morini, S; Battista, C; Guerriero, G; Altomare, V; Tonini, G; Rabitti, C
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters
2006 Perrone, G; Santini, D; Zagami, Mg; Vincenzi, B; Verzi', A; Morini, S; Borzomati, D; Coppola, R; Antinori, A; Magistrelli, P; Tonini, G; Rabitti, C
Deregulation of dicer and mir-155 expression in liposarcoma
2015 Vincenzi, B; Iuliani, M; Zoccoli, A; Pantano, F; Fioramonti, M; De Lisi, D; Frezza, Am; Rabitti, C; Perrone, G; Onetti Muda, A; Russo, A; Giordano, A; Santini, D; Dei Tos, Ap; Tonini, G.
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients
2013 Vincenzi, B; Zoccoli, A; Schiavon, G; Iuliani, M; Pantano, F; Dell'Aquila, E; Ratta, R; Muda, Ao; Perrone, G; Brunelli, C; Correale, P; Riva, E; Russo, A; Loupakis, F; Falcone, A; Santini, D; Tonini, G.
EVALUATION OF COX-2 EXPRESSION IN LOBULAR INTRAEPITHEPIAL NEOPLASIA
2005 Zagami, M; Perrone, G; Bianchi, A; Santini, D; Vincenzi, B; Altomare, V; Tonini, G; Rabitti, C
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases
2011 Santini, D; Perrone, G; Roato, I; Godio, L; Pantano, F; Grasso, D; Russo, A; Vincenzi, B; Fratto, Me; Sabbatini, R; Della Pepa, C; Porta, C; Del Conte, A; Schiavon, G; Berruti, A; Tomasino, Rm; Papotti, M; Papapietro, N; Onetti Muda, A; Denaro, V; Tonini, G.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A RARE CASE OF SOLITARY FIBROUS TUMOUR OF THE PRE-SACRAL SPACE: MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL FEATURES. | 2005 | E., Cristi; Perrone, Giuseppe; C., Battista; BENEDETTI PANICI, Pierluigi; C., Rabitti | |
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer | 2006 | Santini, D; Altomare, A; Vincenzi, B; Perrone, G; Bianchi, A; Rabitti, C; Montesarchio, V; Esposito, V; Baldi, A; Tonini, G. | |
ANGIOGENESIS AND ONCOGENES IN COLON CANCER | 2004 | Perrone, G; Verz, A; Vincenzi, B; Santini, D; Tonini, G; Vetrani, A; Rabitti, C | |
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival | 2013 | Morini, S; Perrone, G; Borzomati, D; Vincenzi, B; Rabitti, C; Righi, D; Castri, F; Manazza, Ad; Santini, D; Tonini, G; Coppola, R; Onetti Muda, A | |
Cell cycle alterations and lung cancer | 2006 | Vincenzi, B; Schiavon, G; Silletta, M; Santini, D; Perrone, G; Di Marino, M; Angeletti, S; Baldi, A; Tonini, G | |
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature | 2014 | Valeri, S; Borzomati, D; Nappo, G; Perrone, G; Santini, D; Coppola, R. | |
Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer | 2004 | Perrone, G; Vincenzi, B; Santini, D; Verzì, A; Tonini, G; Vetrani, A; Rabitti, C. | |
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables | 2006 | Perrone, G; Santini, D; Verzì, A; Vincenzi, B; Borzomati, D; Vecchio, F; Coppola, R; Antinori, A; Magistrelli, P; Tonini, G; Rabitti, C | |
COX-2 EXPRESSION IN AMPULLARY CARCINOMAS: CORRELATION WITH HISTOPATHOLOGIC TYPE AND CLINICO-PATHOLOGICAL PARAMETERS | 2005 | Perrone, G; Verz, A; Santini, D; Vincenzi, B; Borzomati, D; DE DOMINICIS, E; Coppola, R; Tonini, G; Rabitti, C | |
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features | 2005 | Perrone, G; Santini, D; Vincenzi, B; Zagami, M; La Cesa, A; Bianchi, A; Altomare, V; Primavera, A; Battista, C; Vetrani, A; Tonini, G; Rabitti, C | |
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma | 2008 | Perrone, G; Santini, D; Zagami, Mg; Vincenzi, B; Verzì, A; Morini, S; Borzomati, D; Coppola, R; Antinori, A; Magistrelli, P; Tonini, G; Rabitti, C | |
COX-2 EXPRESSION IN DUCTAL AND LOBULAR INTRAEPITHELIAL NEOPLASIA OF BREAST CANCER | 2005 | Zagami, M; Perrone, G; Bianchi, A; Santini, D; Vincenzi, B; Altomare, V; Tonini, G; Rabitti, C | |
COX-2 EXPRESSION IN INTRADUCTAL BREAST CARCINOMA | 2004 | Perrone, G; Zagami, M; Santini, D; Vincenzi, B; Bianchi, A; LA CESA, A; Altomare, V; Primavera, A; Battista, C; Vetrani, A; Tonini, G; Rabitti, C | |
COX-2 EXPRESSION IN LOBULAR CARCINOMA IN SITU | 2005 | Zagami, M; Perrone, G; Bianchi, A; Santini, D; Vincenzi, B; Altomare, V; Primavera, A; Lescarini, G; Tonini, G; Rabitti, C | |
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification | 2007 | Perrone, G; Zagami, M; Santini, D; Vincenti, B; Gullotta, G; Morini, S; Battista, C; Guerriero, G; Altomare, V; Tonini, G; Rabitti, C | |
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters | 2006 | Perrone, G; Santini, D; Zagami, Mg; Vincenzi, B; Verzi', A; Morini, S; Borzomati, D; Coppola, R; Antinori, A; Magistrelli, P; Tonini, G; Rabitti, C | |
Deregulation of dicer and mir-155 expression in liposarcoma | 2015 | Vincenzi, B; Iuliani, M; Zoccoli, A; Pantano, F; Fioramonti, M; De Lisi, D; Frezza, Am; Rabitti, C; Perrone, G; Onetti Muda, A; Russo, A; Giordano, A; Santini, D; Dei Tos, Ap; Tonini, G. | |
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients | 2013 | Vincenzi, B; Zoccoli, A; Schiavon, G; Iuliani, M; Pantano, F; Dell'Aquila, E; Ratta, R; Muda, Ao; Perrone, G; Brunelli, C; Correale, P; Riva, E; Russo, A; Loupakis, F; Falcone, A; Santini, D; Tonini, G. | |
EVALUATION OF COX-2 EXPRESSION IN LOBULAR INTRAEPITHEPIAL NEOPLASIA | 2005 | Zagami, M; Perrone, G; Bianchi, A; Santini, D; Vincenzi, B; Altomare, V; Tonini, G; Rabitti, C | |
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases | 2011 | Santini, D; Perrone, G; Roato, I; Godio, L; Pantano, F; Grasso, D; Russo, A; Vincenzi, B; Fratto, Me; Sabbatini, R; Della Pepa, C; Porta, C; Del Conte, A; Schiavon, G; Berruti, A; Tomasino, Rm; Papotti, M; Papapietro, N; Onetti Muda, A; Denaro, V; Tonini, G. |